Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
K-Fast Holding B | KFASTB | Apr 22, 2024 | 18.70 | +0.54 |
K2A Knaust & Andersson Fastigheter B | K2AB | Apr 22, 2024 | 9.80 | -1.80 |
K2A Knaust & Andersson Fastigheter Pref | K2APREF | Apr 22, 2024 | 204.00 | -0.49 |
KABE Group B | KABEB | Apr 22, 2024 | 330.00 | -0.60 |
Kakel Max | KAKEL | Apr 22, 2024 | 9.00 | 0.00 |
Kallebäck Property Invest | KAPIAB | Apr 22, 2024 | 185.00 | +1.65 |
Kambi Group | KAMBI | Apr 22, 2024 | 87.75 | +0.92 |
Kancera | KAN | Apr 22, 2024 | 1.50 | +0.94 |
Karnell Group AB (publ) | KARNELB | 0.00 | 0.00 | |
Karnov Group | KAR | Apr 22, 2024 | 63.40 | -0.78 |
Karolinska Development B | KDEV | Apr 22, 2024 | 1.51 | -0.79 |
Katalysen Ventures AB | KAV | Apr 22, 2024 | 17.90 | -0.56 |
KebNi B | KEBNIB | Apr 22, 2024 | 1.54 | +1.72 |
Kentima Holding B | KENH | Apr 22, 2024 | 2.02 | +12.85 |
Kiliaro | KILI | Apr 22, 2024 | 1.00 | -4.76 |
Kindred Group SDB | KINDSDB | Apr 22, 2024 | 123.20 | -0.40 |
Kinnevik A | KINVA | Apr 22, 2024 | 115.20 | +2.13 |
Kinnevik B | KINVB | Apr 22, 2024 | 115.60 | +2.76 |
Kjell Group | KJELL | Apr 22, 2024 | 18.80 | -1.05 |
KlaraBo | KLARAB | Apr 22, 2024 | 18.88 | -0.11 |
Klaria Pharma Holding | KLAR | Apr 22, 2024 | 0.28 | +13.88 |
Klimator | KLIMAT | Apr 22, 2024 | 1.51 | +2.03 |
Knowit | KNOW | Apr 22, 2024 | 147.40 | -0.54 |
Kollect on Demand Holding | KOLL | Apr 22, 2024 | 0.69 | -0.29 |
Kontigo Care | KONT | Apr 22, 2024 | 2.30 | -2.13 |
Kopparbergs B | KOBRB | Apr 22, 2024 | 117.50 | +0.43 |
Kopy Goldfields | KOPY | Apr 22, 2024 | 0.30 | 0.00 |
Krona Public Real Estate | KRONA | Apr 22, 2024 | 37.80 | 0.00 |
Kvix | KVIX | Apr 22, 2024 | 0.24 | 0.00 |
Lagercrantz Group B | LAGRB | Apr 22, 2024 | 159.90 | +0.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.